Related Experiment Video
Updated: Apr 6, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Corticosteroids in Pediatric Shock: A Call to Arms
11Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada. 2Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH.
Designing a definitive trial for corticosteroid use in pediatric septic shock requires addressing key issues. These include defining the patient group, ensuring equipoise, selecting appropriate outcomes, and managing side effects for this critical condition.
Area of Science:
- Pediatric critical care medicine
- Pharmacology
- Clinical trial design
Background:
- Corticosteroid use in pediatric septic shock is of significant interest.
- A definitive randomized controlled trial (RCT) is lacking.
- Previous studies have explored adrenal function and steroid use in critically ill children.
Purpose of the Study:
- To identify critical issues for designing and implementing a definitive RCT on adjunctive corticosteroid use in pediatric septic shock.
- To outline the necessary steps for a successful clinical trial in this area.
- To facilitate the initiation of a much-needed research study.
Main Methods:
- Systematic review of pediatric studies from MEDLINE and Embase databases (1946–2015).
- Focused on adrenal function and steroid use in critically ill children with systemic inflammatory response syndrome, sepsis, or septic shock.
- Discussion of relevant points from the reviewed literature.
Main Results:
- Several issues must be resolved before a definitive RCT can be conducted.
- These include identifying the precise target population for the trial.
- Achieving equipoise among clinicians and the community is essential.
- Selecting a patient-centered, clinically meaningful primary outcome measure is crucial.
- Careful consideration of potential adverse effects of corticosteroids is necessary.
Conclusions:
- The time is appropriate to conduct a trial on corticosteroids in pediatric septic shock.
- The central question is whether corticosteroids benefit some children without causing harm.
- Conducting such a trial requires a collaborative effort from ethics boards, families, clinicians, and researchers.
- An international planning meeting is proposed to reach agreement on identified issues.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

